We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Internet Portal Set to Assist Drug Discovery Studies

By LabMedica International staff writers
Posted on 02 Feb 2011
A sophisticated new Internet portal designed to promote and assist drug discovery studies will give researchers in medicinal chemistry, pharmacology, drug metabolism, and pharmacokinetics access to a range of up-to-date databases containing a vast amount of information.

The new web portal is the brainchild of the French company Aureus Sciences (Paris, France), formerly called Aureus Pharma. More...
The portal will provide easy access to its content through a series of sophisticated search and index applications.

Experts at Aureus Sciences continuously monitor and organize the most relevant information from the scientific literature, including experimental in vitro and in vivo protocols. This detailed knowledge forms the "AurSCOPE” database line, focusing on the human body's main therapeutic targets: GPCRs (G protein-coupled receptors), kinases, ion channels, proteases, and nuclear receptors. Additional "AurSCOPE” databases relate to safety, toxicology, and pharmacokinetics. Applications include "AurQUEST,” the web-based query tool, "DDI Predict” for drug-drug interactions, and "AurPROFILER”, the compound profiling visualization tool.

"The new Aureus-Sciences application portal is a major achievement for our company,” said Dr. Jason Theodosiou, president and CEO of Aureus Sciences. "For the first time we are offering a unique single-point access to all of our tools, applications, notes, scientific communications, and technical documentation. This will make it substantially easier for our prospective customers to make use of our know-how, provide more comprehensive interaction, and help them accelerate their research projects with data they can trust.”

Related Links:

Aureus Sciences




New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Laboratory Software
ArtelWare
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.